Compagnie Stéphanoise de Santé (‘C2S’) is a leading independent operator of clinics in the Rhône-Alpes region of France, operating polyclinics that offer both general as well as specialist medicine and surgery.
C2S's strategy is based on having a strong regional presence and local market leadership, a governance model that favours close involvement of practitioners in management and a selective 'buy and build' strategy to consolidate its regional position. Bridgepoint Development Capital works with management on initiatives to improve overall profitability of its clinic portfolio.
C2S was sold to Eurazeo in
To learn more about the company, visit www.groupec2s.fr